Trial Profile
A phase I study of ISIS-TTRRx in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Apr 2015
Price :
$35
*
At a glance
- Drugs Inotersen (Primary)
- Indications Amyloid polyneuropathy
- Focus Adverse reactions; Pharmacokinetics
- 24 Apr 2015 New trial record